IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $446,000 | -57.8% | 9,931 | -46.9% | 0.04% | -55.8% |
| Q4 2020 | $1,056,000 | -62.4% | 18,685 | -59.9% | 0.09% | +1.2% |
| Q4 2019 | $2,811,000 | -68.3% | 46,546 | -66.3% | 0.08% | -75.3% |
| Q2 2019 | $8,877,000 | +89.8% | 138,126 | +139.6% | 0.34% | +27.4% |
| Q1 2019 | $4,678,000 | +1371.1% | 57,639 | +876.9% | 0.27% | +1587.5% |
| Q4 2018 | $318,000 | -66.1% | 5,900 | -67.6% | 0.02% | -51.5% |
| Q3 2018 | $938,000 | -79.7% | 18,200 | -80.0% | 0.03% | -52.9% |
| Q2 2017 | $4,629,000 | +286.7% | 91,000 | +77.0% | 0.07% | +25.0% |
| Q2 2016 | $1,197,000 | -37.4% | 51,400 | +66.3% | 0.06% | -51.7% |
| Q4 2015 | $1,913,000 | – | 30,900 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |